Stock screener

CRDF

Broke outConviction 26LongHealthcareScan · Tue, Sep 8, 2026
Symmetrical triangleSpinning toptriangle
CRDF$1.10+0.92%
ResistanceSupportVol 14Insider buy
63 bars
4
2
Vol MA14 618.03K
Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8

Trade plan

Long
Entry
Entry
1.10
Risk
Stop
0.9164
-16.7% to stop
Reward
Target 1
—
Stretch
Target 2
—

Levels are derived from the pattern's structure (resistance, support and ATR) — a mechanical plan, not financial advice. Size positions to your own risk tolerance.

Cardiff Oncology, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.cardiffoncology.com ↗
Price1.10
Change+0.92%
Gap+1.83%
Rel volume0.46×
Avg volume651.64K
Avg $ vol643.22K
SMA 200.9873
SMA 501.02
SMA 2001.71
Price vs 50+8.05%
Price vs 200-35.79%
MA stackmixed
50/200 cross—
Supertrendup · 0.8898
RSI (14)61
MACD hist0.02
MACD cross—
Stoch %K / %D88 / 93
ADX (14)20
+DI / −DI26 / 14
RSI divergence—
MACD divergence—
ATR %+6.53%
ADR %7.10%
52w high3.21
52w low0.8100
From 52w high-65.73%
Above 52w low+35.80%
New 52w highNo
SqueezeOff
Bollinger width27.14%
%B0.92
Donchian pos88.59%
Donchian high1.13
Donchian low0.8670
AVWAP (52w high)1.58
vs AVWAP high-30.18%
AVWAP (52w low)0.9577
vs AVWAP low+14.86%
OBV trendUp
Chaikin MF (20)-0.11
Today vs 20d0.46×
Avg vol (14d)618.03K
Avg vol (20d)651.64K
Avg $ vol (20d)643.22K
Market cap85.57M
RS 3m (vs SPY)-31.76%
RS 6m (vs SPY)-56.57%
RS line new highNo
Trend template2/8
Technical rank37.8
1 week+10.71%
1 month+10.90%
3 months-26.67%
6 months-44.72%
1 year-49.31%
YTD-58.65%
P/E-1.87
P/B3.23
P/S144.31
P/FCF-2.25
EPS-0.6900
Div yield—
ROE-172.81%
ROA-122.83%
Debt/Eq—
Current3.30
EV/EBITDA-1.57
Gross margin—
Net margin—
Rev growth-13.18%
EPS growth-0.92%
Price target6.00
Target upside445.45%
Analyst ratingHold
Institutional26.33%
Ent. value76.38M
Revenue104K
Net income-9.23M
Gross profit—
Free cash flow-37.97M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out68.37M
Employees31
ListedThu, May 22, 1997
Free float64.31M
Float %94.1%
Short interest11.9M
Days to cover15.3d
Short volume70.3%
Squeeze score82 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.14 vs −$0.17
Last surprise+17.6% beat
Setup gradeD
Conviction26 / 100
Pattern quality50%
Tech rank37.8 / 100
Group rank96 / 100 · Leading
Status laneBroke out
Setup directionLong
Pattern familyTriangle
Resistance1.00
Support0.9343
Days since event4d
Candle confirmSpinning top
News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in CRDF

All disclosures →
No recent disclosed trades by Congress in CRDF. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in CRDF · 9 buys

InsiderSideShares
Mohindru Mani
Chief Executive Officer · Common Stock Purchase Warrant · 2026-07-14
Buy34.36K
Mohindru Mani
Chief Executive Officer · Common Stock · 2026-07-14
Buy34.36K
PACE GARY W
Director · Common Stock · 2026-07-14
Buy687.28K
PACE GARY W
Director · Common Stock Purchase Warrant · 2026-07-14
Buy687.28K
Mohindru Mani
Chief Executive Officer · Common Stock · 2026-06-18
Buy24.7K
PACE GARY W
Director · Common Stock · 2026-06-18
Buy30K
Aggarwal Ajay
Chief Operating Officer · Stock Options · 2026-04-27
Grant400K
Smeal Tod
Chief Scientific Officer · Stock Options · 2026-04-14
Grant300K
Muntner Joshua B
Chief Financial Officer · Common Stock · 2026-04-06
Other—
Muntner Joshua B
Chief Financial Officer · Stock Options · 2026-04-06
Grant486.65K

SEC filings

EDGAR filings in CRDF · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.